What Will Separate Healthcare AI Winners From Losers?

Uma Veerappan of Flare Capital Partners thinks the healthcare AI startups that will come out on top will be companies that integrate seamlessly into workflows, build proprietary datasets and quickly determine how to sell their technology. The post What Will Separate Healthcare AI Winners From Losers? appeared first on MedCity News.

Read More

Immunology Startup Merida Bio Unveils $121M and a Lead Program for Graves’ Disease

Merida Biosciences is developing antibody-like drugs designed to selectively eliminate disease-driving autoantibodies while sparing healthy components of the immune system. Graves disease, which stems from the immune system’s attack on the thyroid gland, is the startup’s lead disease target. The post Immunology Startup Merida Bio Unveils $121M and a Lead Program for Graves’ Disease appeared…

Read More

Links

Tyler Cowen on the price of Ozempic.Problems with the OMB’s social welfare function. Link between alcohol and cancer. Disparities in the rural-urban life expectancy.Why will Part D plans “…move drugs that are selected for [MFP] negotiation into a higher cost-sharing tier”?

Read More

Solving the Home Care Quandary

You’re ready to leave the hospital, but you don’t feel able to care for yourself at home yet. Or, you’ve completed a couple of weeks in rehab. Can you handle your complicated medication regimen, along with shopping and cooking? Perhaps you fell in the shower, and now your family wants you to arrange help with…

Read More

Ratnakar Lavu, Elevance

Ratnakar Lavu is the Chief Digital Information Officer of Elevance, the holding company of Blue Cross and Blue Shield plans in some 14 states (usually called Anthem Blue Cross). We had a great chat about what the priorities are for Elevance, and Ratnakar’s goal is to use tech to make the member experience simple. They…

Read More